BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22200136)

  • 1. Combining functional imaging with brain stimulation in Parkinson's disease.
    Obeso I; Ray NJ; Antonelli F; Cho SS; Strafella AP
    Int Rev Psychiatry; 2011 Oct; 23(5):467-75. PubMed ID: 22200136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional neuroimaging and repetitive transcranial magnetic stimulation in Parkinson's disease.
    Wu AD
    Rev Neurol Dis; 2007; 4(1):1-9. PubMed ID: 17514152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystonia.
    Rothwell J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S417-20. PubMed ID: 18267274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease.
    Helmich RC; Siebner HR; Bakker M; Münchau A; Bloem BR
    J Neurol Sci; 2006 Oct; 248(1-2):84-96. PubMed ID: 16793065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation.
    Arantes PR; Cardoso EF; Barreiros MA; Teixeira MJ; Gonçalves MR; Barbosa ER; Sukwinder SS; Leite CC; Amaro E
    Mov Disord; 2006 Aug; 21(8):1154-62. PubMed ID: 16671094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-selectivity of a thalamocortical relay neuron during Parkinson's disease and deep brain stimulation: a computational study.
    Cagnan H; Meijer HG; van Gils SA; Krupa M; Heida T; Rudolph M; Wadman WJ; Martens HC
    Eur J Neurosci; 2009 Oct; 30(7):1306-17. PubMed ID: 19788577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease.
    Kuriakose R; Saha U; Castillo G; Udupa K; Ni Z; Gunraj C; Mazzella F; Hamani C; Lang AE; Moro E; Lozano AM; Hodaie M; Chen R
    Cereb Cortex; 2010 Aug; 20(8):1926-36. PubMed ID: 20019146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of subthalamic nucleus deep brain stimulation on physical, emotional, cognitive functions and daily living activities in patients with Parkinson's disease.
    Altug F; Acar F; Acar G; Cavlak U
    Turk Neurosurg; 2011; 21(2):140-6. PubMed ID: 21534193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking brain dynamics, neural mechanisms, and deep brain stimulation in Parkinson's disease: an integrated perspective.
    Modolo J; Beuter A
    Med Eng Phys; 2009 Jul; 31(6):615-23. PubMed ID: 19243986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease.
    Castrioto A; Meaney C; Hamani C; Mazzella F; Poon YY; Lozano AM; Hodaie M; Moro E
    Neurobiol Dis; 2011 Jan; 41(1):131-7. PubMed ID: 20826212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease.
    Naskar S; Sood SK; Goyal V; Dhara M
    Brain Res Rev; 2010 Oct; 65(1):1-13. PubMed ID: 20457181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2006 Dec; 129(Pt 12):3366-75. PubMed ID: 17077105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation for Parkinson's disease: patient selection and motor outcomes.
    Chang VC; Chou KL
    Med Health R I; 2006 Apr; 89(4):142-4. PubMed ID: 16676911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation.
    Breit S; Schulz JB; Benabid AL
    Cell Tissue Res; 2004 Oct; 318(1):275-88. PubMed ID: 15322914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern.
    Strafella AP; Lozano AM; Lang AE; Ko JH; Poon YY; Moro E
    Mov Disord; 2007 Oct; 22(14):2113-6. PubMed ID: 17894326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease.
    Denheyer M; Kiss ZH; Haffenden AM
    Neuropsychologia; 2009 Dec; 47(14):3203-9. PubMed ID: 19664645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.